Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

STEPHEN PAN

Allopathic & Osteopathic Physicians Internal Medicine Advanced Heart Failure and Transplant Cardiology

NPI
1952581779
CMS profile
315577
Location
VALHALLA, NY

General Payments · PY2018–2024

$84,213.72

  • Reported across 117 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$38,790.29

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Alnylam Pharmaceuticals Inc. $23,544.63 18
PFIZER INC. $13,524.40 6
Acerta Pharma LLC $1,450.00 4
Daxor Corporation $101.56 1
ABIOMED $74.88 2
Merck Sharp & Dohme Corporation $50.19 3
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $44.63 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $497.01 22
PY2019 $1,281.18 13
PY2020 $10,543.66 9
PY2021 $2,794.63 9
PY2022 $10,759.97 10
PY2023 $19,546.98 18
PY2024 $38,790.29 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABIOMED $31.89 01/19/2024 Food and Beverage Undisputed 01/23/2026 1142267010 CMS
ABIOMED $42.99 03/01/2024 Food and Beverage Undisputed 01/23/2026 1142267050 CMS
Alnylam Pharmaceuticals Inc. $2,820.00 03/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1125822841 CMS
Alnylam Pharmaceuticals Inc. $1,057.50 03/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1125822843 CMS
Alnylam Pharmaceuticals Inc. $125.01 03/14/2024 Food and Beverage Undisputed 01/23/2026 1125822859 CMS
Alnylam Pharmaceuticals Inc. $144.78 03/15/2024 Travel and Lodging Undisputed 01/23/2026 1125822857 CMS
Alnylam Pharmaceuticals Inc. $3,525.00 03/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1125822853 CMS
Alnylam Pharmaceuticals Inc. $161.78 03/20/2024 Travel and Lodging Undisputed 01/23/2026 1125822855 CMS
Alnylam Pharmaceuticals Inc. $123.00 04/11/2024 Food and Beverage Undisputed 01/23/2026 1125822883 CMS
Alnylam Pharmaceuticals Inc. $3,173.00 04/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1125822879 CMS
Alnylam Pharmaceuticals Inc. $134.49 04/24/2024 Travel and Lodging Undisputed 01/23/2026 1125822881 CMS
Alnylam Pharmaceuticals Inc. $196.47 06/06/2024 Travel and Lodging Undisputed 01/23/2026 1125822913 CMS
Alnylam Pharmaceuticals Inc. $89.53 06/06/2024 Food and Beverage Undisputed 01/23/2026 1125822915 CMS
Alnylam Pharmaceuticals Inc. $3,173.00 07/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1125822909 CMS
Alnylam Pharmaceuticals Inc. $113.23 07/12/2024 Travel and Lodging Undisputed 01/23/2026 1125822911 CMS
Alnylam Pharmaceuticals Inc. $2,115.00 08/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1125823023 CMS
Alnylam Pharmaceuticals Inc. $121.84 08/22/2024 Food and Beverage Undisputed 01/23/2026 1125823043 CMS
Alnylam Pharmaceuticals Inc. $3,173.00 09/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1125823041 CMS
Alnylam Pharmaceuticals Inc. $125.00 10/10/2024 Food and Beverage Undisputed 01/23/2026 1125823077 CMS
Alnylam Pharmaceuticals Inc. $3,173.00 11/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1125823075 CMS
AstraZeneca Pharmaceuticals LP $300.00 01/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104356343 CMS
AstraZeneca Pharmaceuticals LP $950.00 09/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104607790 CMS
AstraZeneca Pharmaceuticals LP $100.00 10/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105595579 CMS
AstraZeneca Pharmaceuticals LP $100.00 10/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104567894 CMS
Daxor Corporation $101.56 03/13/2024 Food and Beverage Undisputed 01/23/2026 1136816433 CMS
Merck Sharp & Dohme LLC $14.75 04/23/2024 Food and Beverage Undisputed 01/23/2026 1141776757 CMS
Merck Sharp & Dohme LLC $16.11 06/11/2024 Food and Beverage Undisputed 01/23/2026 1141896543 CMS
Merck Sharp & Dohme LLC $19.33 10/08/2024 Food and Beverage Undisputed 01/23/2026 1141896545 CMS
PFIZER INC. $104.52 03/18/2024 Travel and Lodging Undisputed 01/23/2026 1131460911 CMS
PFIZER INC. $123.50 03/19/2024 Food and Beverage Undisputed 01/23/2026 1131502960 CMS
PFIZER INC. $4,250.00 03/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131470724 CMS
PFIZER INC. $3,125.00 06/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131790969 CMS
PFIZER INC. $71.38 10/31/2024 Travel and Lodging Undisputed 01/23/2026 1130891662 CMS
PFIZER INC. $5,850.00 11/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1130891660 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $20.57 09/12/2024 Food and Beverage Undisputed 01/23/2026 1080703122 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $24.06 11/26/2024 Food and Beverage Undisputed 01/23/2026 1080703202 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.